AzTrials
AzTrials

Intervention (Training) ConditionWeBREATHe IINCT01642264

Web-Based Respiratory Education About Tobacco and Health Phase II

A study testing WeBREATHe Training Program in people with Intervention (Training) Condition and Control (Delayed Training) Condition, run by Oregon Research Institute.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The primary aim of this study was to develop an interactive Internet-based program (WeBREATHe: Web-Based Respiratory Education About Tobacco and Health) to train pediatric respiratory therapists and nurses to provide brief, hospital-based tobacco cessation interventions to parents of pediatric patients. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
WeBREATHe Training Program
Could I receive a placebo?
No, everyone receives an active treatment
How many people
217 participants
Where
No sites listed yet
Study dates
Mar 2008to Dec 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Must be a respiratory Therapist, nurse or nurse practitioner at the 2 pediatric hospitals participating in the study.
  • Must be at least 18 years of age.

Who cannot join

  • Under 18 years of age.

About this study

Official title: Web-Based Respiratory Education About Tobacco and Health (WeBREATHe) Phase II

The primary aim of this study was to develop an interactive Internet-based program (WeBREATHe: Web-Based Respiratory Education About Tobacco and Health) to train pediatric respiratory therapists and nurses to provide brief, hospital-based tobacco cessation interventions to parents of pediatric patients. The WeBREATHe program was based on a Phase I prototype which was evaluated with 50 pediatric respiratory therapists and nurses.

In Phase II, the investigators redesigned and expanded the program with input from 50 educators, nurses and respiratory therapists from Cincinnati Children's Hospital Medical Center. Then the investigators evaluated the Phase II program in a randomized trial in which 215 respiratory therapists and nurses from two large, urban children's hospitals were randomly assigned within hospital to either the Intervention (Training) Condition, or to a Delayed Treatment (Training) Control condition.

Read more

Participants' demographic and tobacco use history were measured at baseline, and tobacco cessation intervention behaviors, attitudes, knowledge, perceived barriers, and self-efficacy regarding delivery of a tobacco cessation intervention were measured at baseline, 1 week post-training, and at 3 months post-training. User satisfaction measures were also collected at 1 week post-training from Intervention Condition participants. The investigators hypothesized that participants in the Intervention Condition would have increased tobacco cessation behaviors, positive attitudes and self-efficacy, and decreased perceived barriers than participants i the Delayed-Treatment Control Condition.

Following evaluation, the investigators developed a final version of the interactive training program and created the administrative infrastructure for a marketable product.

Being tested
WeBREATHe Training Program
Keywords
Tobacco Cessation, Continuing Education, Pediatric, Respiratory Therapist, Nurse
Medical subject headings
Tobacco Use Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WeBREATHe Training ProgramBehavioural

    The WeBREATHe Training Program is a web-based, interactive training program to teach pediatric respiratory therapists, nurses and nurse practitioners how to help their patients' parents to quit smoking.

Study groups in NCT01642264
Study groupRoleWhat they receive
Control (Delayed Training) ConditionNo interventionParticipants in this condition were assessed at 1 week, 1 month and 3 months post-enrollment, and were provided access to the WeBREATHe training website upon completion of their 3-month assessment.
Intervention (Training) ConditionExperimentalIn this condition, participants used the WeBREATHe training program website for 1 week, and completed assessments at 1 week, 1 month, and 3 months post-training.
Receives: Behavioral: WeBREATHe Training Program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Performance of Ask, Advise, Assess, Assist and Arrange Behaviors

    14 items measured on a 5-point Likert scale of frequency. Ask = asking all patients' parents about tobacco use and documenting use in the patients' charts.

    Advise = discussing health hazards of tobacco use and giving direct advice to quit.

    Assess = determining parents' level of readiness to quit. Assist = discussing strategies or techniques to quit, setting a specific date to quit, discussing pharmacotherapy for tobacco cessation, giving written self-help materials to tobacco users.

    Arrange = discussing local tobacco cessation resources and making a referral to a tobacco quit line.

    Measured: 3 months post-enrollment

Secondary outcomes (3)
  1. Attitudes towards provision of tobacco cessation interventions

    9 items. Level of agreement measured on a 5-point Likert scale on 9 statements measuring attitudes towards provision of tobacco cessation interventions to patients' parents in pediatric settings. For example, "It is appropriate for pediatric RTs and RNs to assess and document their patients' exposure to secondhand smoke (e.g., family members' tobacco use)."

    Measured: 3 months post-enrollment

  2. Perceived Barriers

    7 items measured on a 5-point Likert scale. Participants rate the level of routine barriers to provision of tobacco cessation interventions in pediatric settings, (e.g., lack of training, lack of time, lack of resources).

    Measured: 3 months post-enrollment

  3. Self-Efficacy

    6 items measured on a 5-point Likert scale. Participants rate their agreement to statements of perceived self-efficacy to perform Ask, Advise, Assess, Assist and Arrange behaviors (e.g., "I can ask my patients' parents about their smoking.")

    Measured: 3 months post-enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2012 (estimated)
  2. Study startMar 2008
  3. Primary completionNov 2010
  4. Study completionDec 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
217 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01642264
Sponsor's protocol ID
HL083540
Acronym
WeBREATHe II
Status last verified
Sep 2023
First submitted
11 Jul 2012
Last updated
26 Sep 2023
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing WeBREATHe Training Program in people with Intervention (Training) Condition and Control (Delayed Training) Condition, run by Oregon Research Institute.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Performance of Ask, Advise, Assess, Assist and Arrange Behaviors (time frame: 3 months post-enrollment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Sep 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in